Qiagen vs Bio-Techne
QGEN and TECH side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How QGEN and TECH compare
Qiagen grew revenue faster over the last twelve months (5.7% versus −0.38% for Bio-Techne).
Bio-Techne pays a dividend yielding 0.44%; Qiagen does not pay one.
Bio-Techne scores higher on the StockData Score (12 against 10 for Qiagen), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | QGEN | TECH |
|---|---|---|
| Size and price | ||
| Market cap | – | $11.4B |
| Share price | $50.22 | $72.66 |
| Change, 1 year | 1.1% | 17.2% |
| Change, 5 years | −12.0% | −41.6% |
| Beta (5Y) | 0.69 | 1.08 |
| Employees | 5,700 | 3,000 |
| StockData Score | ||
| Total score | 10 | 12 (better) |
| Valuation score | 0 | 2 (better) |
| Growth score | 2 (better) | 1 |
| Performance score | 4 (better) | 0 |
| Health score | 4 | 6 (better) |
| Dividend score | 0 | 3 (better) |
| Valuation | ||
| P/E | – | 62.6× |
| P/S | – | 9.4× |
| P/B | – | 5.4× |
| EV/EBITDA | – | 32.4× |
| P/FCF | – | 43.3× |
| FCF yield | – | 2.3% |
| Fair value | – | $52.72 |
| Margin of safety | – | −37.8% |
| Growth | ||
| Revenue growth (TTM) | 5.7% (better) | −0.38% |
| Revenue growth, 5Y average | 2.2% | 5.5% (better) |
| Net income growth (TTM) | 408% | – |
| EPS growth (TTM) | 424% (better) | 152% |
| EPS growth, 5Y average | 4.9% | 5.9% (better) |
| Profitability | ||
| Gross margin | 62.2% | 65.8% (better) |
| Operating margin | 22.3% (better) | 20.7% |
| Net margin | 20.3% | – |
| FCF margin | 21.7% (better) | 21.7% |
| Return on equity | 11.6% | – |
| Return on invested capital | 9.9% (better) | 9.2% |
| Financial health | ||
| Debt / equity | 0.44 | 0.09 (better) |
| Net debt / EBITDA | 0.84 (better) | −0.19 |
| Interest coverage | 14.0× | 26.2× (better) |
| Current ratio | 3.90 | 4.55 (better) |
| Altman Z-score | – | 15.97 |
| Piotroski F-score | 8 | – |
| Dividends and buybacks | ||
| Dividend yield | – | 0.44% |
| Payout ratio | 12.8% | – |
| Years of dividend growth | 0 | 0 |
| Dividend growth, 5Y average | – | 0.00% |
| Buyback yield | – | 0.37% |
| Shareholder yield | – | 0.81% |
| Ownership | ||
| Held by institutions | 67.4% | 112% |
| Held by insiders | 0.00% | 0.35% |
| Insider net buying, 12 months | – | −$437K |
| Superinvestors holding | – | 4 |
| Short interest, % of float | 3.5% | 4.7% |
Go deeper
- QGEN stock overview
- QGEN income statement
- QGEN valuation and score
- TECH stock overview
- TECH income statement
- TECH valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.